Journal article
Dosimetry-based treatment for Graves’ disease
Abstract
OBJECTIVE: The aim of this retrospective study was to assess the long-term outcome of a personalized dosimetry approach in Graves' disease aiming to render patients euthyroid from a planned thyroid absorbed dose of 60 Gy.
PATIENTS AND METHODS: A total of 284 patients with Graves' disease were followed prospectively following administration of radioiodine calculated to deliver an absorbed dose of 60 Gy. Patients with cardiac disease were …
Authors
Hyer SL; Pratt B; Gray M; Chittenden S; Du Y; Harmer CL; Flux GD
Journal
Nuclear Medicine Communications, Vol. 39, No. 6, pp. 486–492
Publisher
Wolters Kluwer
Publication Date
June 2018
DOI
10.1097/mnm.0000000000000826
ISSN
0143-3636